(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide...
Stats | |
---|---|
今日成交量 | 700 939 |
平均成交量 | 657 718 |
市值 | 59.07B |
EPS | €0 ( 2024-02-01 ) |
下一个收益日期 | ( €0.520 ) 2024-05-06 |
Last Dividend | €0.950 ( 2023-02-16 ) |
Next Dividend | €0 ( N/A ) |
P/E | 39.21 |
ATR14 | €0.0180 (0.03%) |
音量 相关性
Siemens Healthineers AG 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Siemens Healthineers AG 相关性 - 货币/商品
Siemens Healthineers AG 财务报表
Annual | 2023 |
营收: | €21.68B |
毛利润: | €7.71B (35.56 %) |
EPS: | €1.350 |
FY | 2023 |
营收: | €21.68B |
毛利润: | €7.71B (35.56 %) |
EPS: | €1.350 |
FY | 2022 |
营收: | €21.71B |
毛利润: | €8.14B (37.47 %) |
EPS: | €1.820 |
FY | 2021 |
营收: | €18.00B |
毛利润: | €6.95B (38.63 %) |
EPS: | €1.724 |
Financial Reports:
No articles found.
Siemens Healthineers AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0.950 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.700 | 2019-02-06 |
Last Dividend | €0.950 | 2023-02-16 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | €4.10 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.9 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.57 | |
Div. Directional Score | 7.83 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SCT.DE | Ex Dividend Knight | 2023-07-27 | Annually | 0 | 0.00% | |
COK.DE | Ex Dividend Junior | 2023-06-15 | Annually | 0 | 0.00% | |
KRN.DE | Ex Dividend Knight | 2023-05-24 | Annually | 0 | 0.00% | |
185.DE | Ex Dividend Junior | 2023-08-07 | Quarterly | 0 | 0.00% | |
TRVC.DE | Ex Dividend Junior | 2023-08-04 | Quarterly | 0 | 0.00% | |
DYH.DE | Ex Dividend Knight | 2023-11-14 | Quarterly | 0 | 0.00% | |
MUX.DE | Ex Dividend Junior | 2023-07-11 | Annually | 0 | 0.00% | |
ADM.DE | Ex Dividend Knight | 2023-08-15 | Quarterly | 0 | 0.00% | |
WUW.DE | Ex Dividend Junior | 2023-05-24 | Annually | 0 | 0.00% | |
FTE.DE | Ex Dividend Knight | 2023-12-04 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0697 | 1.500 | 8.61 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0333 | 1.200 | 8.89 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0862 | 1.500 | -0.153 | -0.230 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.116 | 0.800 | 9.42 | 7.54 | [1 - 3] |
quickRatioTTM | 0.697 | 0.800 | -0.608 | -0.486 | [0.8 - 2.5] |
cashRatioTTM | 0.118 | 1.500 | -0.455 | -0.682 | [0.2 - 2] |
debtRatioTTM | 0.0147 | -1.500 | 9.75 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 6.52 | 1.000 | 8.70 | 8.70 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.12 | 2.00 | 9.29 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.430 | 2.00 | 9.28 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0376 | -1.500 | 9.85 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.359 | 1.000 | 7.35 | 7.35 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.107 | 1.000 | 9.86 | 9.86 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.53 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.478 | 0.800 | -0.144 | -0.116 | [0.5 - 2] |
Total Score | 10.09 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.91 | 1.000 | 6.17 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0862 | 2.50 | -0.0985 | -0.230 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.430 | 2.00 | 9.52 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.794 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.12 | 2.00 | 9.29 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 2.44 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.109 | 1.000 | 9.78 | 0 | [0.1 - 0.5] |
Total Score | 5.57 |
Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。